Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
Correction of the nonlinear dose response improves the viability of adenoviral vectors for gene therapy of Fabry disease. [electronic resource] by
- Ziegler, Robin J
- Li, Chester
- Cherry, Maribeth
- Zhu, Yunxiang
- Hempel, Donna
- van Rooijen, Nico
- Ioannou, Yiannis A
- Desnick, Robert J
- Goldberg, Mark A
- Yew, Nelson S
- Cheng, Seng H
Producer: 20021204
In:
Human gene therapy vol. 13
Availability: No items available.
|
|
12.
|
AAV2 vector harboring a liver-restricted promoter facilitates sustained expression of therapeutic levels of alpha-galactosidase A and the induction of immune tolerance in Fabry mice. [electronic resource] by
- Ziegler, Robin J
- Lonning, Scott M
- Armentano, Donna
- Li, Chester
- Souza, David W
- Cherry, Maribeth
- Ford, Christine
- Barbon, Christine M
- Desnick, Robert J
- Gao, Guangping
- Wilson, James M
- Peluso, Richard
- Godwin, Simon
- Carter, Barrie J
- Gregory, Richard J
- Wadsworth, Samuel C
- Cheng, Seng H
Producer: 20040917
In:
Molecular therapy : the journal of the American Society of Gene Therapy vol. 9
Availability: No items available.
|